Behavioral and cellular pharmacology characterization of 17-cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6α-(isoquinoline-3'-carboxamido)morphinan (NAQ) as a mu opioid receptor selective ligand.
about
Synthesis and characterization of a dual kappa-delta opioid receptor agonist analgesic blocking cocaine reward behaviorAntinociceptive Interactions between the Imidazoline I2 Receptor Agonist 2-BFI and Opioids in Rats: Role of Efficacy at the μ-Opioid Receptor.17-Cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6β-(4'-pyridylcarboxamido)morphinan (NAP) Modulating the Mu Opioid Receptor in a Biased FashionApplication of receptor theory to the design and use of fixed-proportion mu-opioid agonist and antagonist mixtures in rhesus monkeys.
P2860
Behavioral and cellular pharmacology characterization of 17-cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6α-(isoquinoline-3'-carboxamido)morphinan (NAQ) as a mu opioid receptor selective ligand.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Behavioral and cellular pharma ...... oid receptor selective ligand.
@ast
Behavioral and cellular pharma ...... oid receptor selective ligand.
@en
type
label
Behavioral and cellular pharma ...... oid receptor selective ligand.
@ast
Behavioral and cellular pharma ...... oid receptor selective ligand.
@en
prefLabel
Behavioral and cellular pharma ...... oid receptor selective ligand.
@ast
Behavioral and cellular pharma ...... oid receptor selective ligand.
@en
P2093
P2860
P1476
Behavioral and cellular pharma ...... oid receptor selective ligand.
@en
P2093
Amanda Braithwaite
Yunyun Yuan
P2860
P304
P356
10.1016/J.EJPHAR.2014.04.041
P407
P577
2014-05-08T00:00:00Z